Entities / Company
Adaptive Biotechnologies.
company in Seattle, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 31
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
The FDA granted authorization for an Investigational Device Exemption (IDE) application involving Adaptive Biotechnologies.Some support1 report
-
Insider at Adaptive Biotechnologies sold shares of the company, disclosed via an SEC filing.Well supported4 reports
-
Adaptive Biotechnologies is evaluating strategic alternatives for its Immune Medicine segment.Some support1 report
-
Adaptive Biotechnologies and Genentech have terminated their strategic collaboration agreement.Some support2 reports
-
Adaptive Biotechnologies and NeoGenomics announced a strategic partnership on June 26, 2025.Speculative1 report
-
The FDA cleared a diagnostic test, with the involved companies being Adaptive Biotechnologies and Fortrea Holdings Inc.Speculative1 report
-
Aristotle Atlantic highlighted Adaptive Biotechnologies as a stock pick in a strategy report.Some support1 report
-
Adaptive Biotechnologies reported results and integrated its clonoSEQ technology into Flatiron’s OncoEMR platform.Some support3 reports
-
Adaptive Biotechnologies and Cardinal Health both outperformed their respective sectors in a report dated August 25, 2025.Some support2 reports
-
Adaptive Biotechnologies, a company, is based in Seattle, Washington.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Adaptive Biotechnologies this week
News at the entities that move Adaptive Biotechnologies most-
FDA StructuralSteven Abrams commented on the FDA's nutrition update review, which is part of a Trump administration initiative.Moves Adaptive Biotechnologies
-
TD Cowen Mentioned togetherWendy's is being analyzed for privatization prospects by TD Cowen amid Middle East war driving commodity price surges.Moves Adaptive Biotechnologies
-
SEC StructuralFranklin Templeton filed with the SEC to launch new ETFs seeking to integrate Bitcoin into its product offerings.Moves Adaptive Biotechnologies
-
Morgan Stanley Mentioned togetherGoldman Sachs and Morgan Stanley noted that semiconductor stocks benefit from current rate levels but face market caution.Moves Adaptive Biotechnologies
-
Glasgow Shared contextRossiya crew was heard near the Babcock International facility in Rosyth, near Glasgow.Moves Adaptive Biotechnologies
-
Seattle Shared contextUsibelli Coal Mine sponsors an Arctic Innovation Competition hosted by the University of Alaska Fairbanks.Moves Adaptive Biotechnologies
Connections
The 7 strongest of 31, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Harlan Robins Transactional
Harlan Robins, identified as an insider, executed a sale of company shares related to Adaptive Biotechnologies.
-
FDA Structural
The company operates under the formal oversight and approval requirements of the FDA.
-
SEC Structural
Adaptive Biotechnologies is subject to formal regulation by the SEC, as evidenced by required disclosures.
-
Glasgow Shared context
Adaptive Biotechnologies presented findings at a meeting held in the city of Glasgow.
-
TD Cowen Mentioned together
TD Cowen provides research reports on Adaptive Biotechnologies.
-
Morgan Stanley Mentioned together
Morgan Stanley provides financial analysis and price targets for Adaptive Biotechnologies.
-
Seattle Shared context
Adaptive Biotechnologies is based and operates within the city of Seattle.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 eventsJune 2026
10 events- The FDA granted authorization for an Investigational Device Exemption (IDE) application involving Adaptive Biotechnologies.
- Insider at Adaptive Biotechnologies sold shares of the company, disclosed via an SEC filing.
- Adaptive Biotechnologies is evaluating strategic alternatives for its Immune Medicine segment.
- Adaptive Biotechnologies and Genentech have terminated their strategic collaboration agreement.
- Adaptive Biotechnologies and NeoGenomics announced a strategic partnership on June 26, 2025.
- The FDA cleared a diagnostic test, with the involved companies being Adaptive Biotechnologies and Fortrea Holdings Inc.
- Aristotle Atlantic highlighted Adaptive Biotechnologies as a stock pick in a strategy report.
- Adaptive Biotechnologies reported results and integrated its clonoSEQ technology into Flatiron’s OncoEMR platform.
- Adaptive Biotechnologies and Cardinal Health both outperformed their respective sectors in a report dated August 25, 2025.
- Adaptive Biotechnologies, a company, is based in Seattle, Washington.